Company profile: Emphasys Medical
1.1 - Company Overview
Company description
- Provider of therapeutic devices for the treatment of patients with emphysema and other breathing disorders, offering the Zephyr Endobronchial Valve system designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Emphasys Medical
PulmoTech
HQ: The Netherlands
Website
- Description: Provider of medical devices for ventilated critically ill patients, including the intelligent Esophageal Pressure Catheter (iEPC) that measures esophageal pressure and administers enteral feeding, enabling continuous pressure monitoring influenced by respiratory muscles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PulmoTech company profile →
Topigen Pharmaceuticals
HQ: Canada
Website
- Description: Provider of biotech R&D developing novel therapeutic drugs, including: adenosine A3 receptor agonists that target immune cells to modulate cytokine release for neuropathic pain; hMC1R-selective tetra- and tripeptide agonists for sunless tanning and reducing UV-induced genotoxicity; Hypidone Hydrochloride (YL-0919) for PTSD; kappa opioid receptor agonists; and MT1/MT2 melatonin receptor agonists for metabolic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Topigen Pharmaceuticals company profile →
ALung
HQ: United States
Website
- Description: Provider of intracorporeal and extracorporeal medical gas exchange devices for the treatment of acute and chronic respiratory disorders, including the Hemolung extracorporeal gas exchange device that circulates blood through a small catheter and the Hattler Catheter.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ALung company profile →
Aerogen
HQ: Ireland
Website
- Description: Provider of innovative medical device and drug delivery solutions specializing in the design, manufacture, and marketing of aerosol drug delivery systems for the critical care respiratory market, featuring patented Vibronic aerosol technology that enables drugs to be nebulized.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aerogen company profile →
Tenax Therapeutics
HQ: United States
Website
- Description: Provider of therapies targeting cardiovascular and pulmonary diseases, developing oral formulations including TNX-201 (enteric-coated imatinib) for pulmonary arterial hypertension to address gastric intolerance and potential disease modification, and TNX-103 (oral levosimendan) for pulmonary hypertension in heart failure with preserved ejection fraction, building on established efficacy in acute heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tenax Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Emphasys Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Emphasys Medical
2.2 - Growth funds investing in similar companies to Emphasys Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Emphasys Medical
4.2 - Public trading comparable groups for Emphasys Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →